Enoxaparin Sodium
NDC Package 55154-5437-5

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Enoxaparin Sodium is enoxaparin is used to prevent and treat harmful blood clots. Marketed by Cardinal Health, this product is identified by NDC 55154-5437 and is authorized under FDA application ANDA077857.

Identification & Billing

NDC Package Code
55154-5437-5
Package Description
5 SYRINGE in 1 BAG / 1 mL in 1 SYRINGE
Product Code
11-Digit Billing Format
55154543705

Clinical Specifications

Proprietary Name
Enoxaparin Sodium
Dosage Form
-
Usage Information
Enoxaparin is used to prevent and treat harmful blood clots. This helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Enoxaparin is an anticoagulant, also known as a "blood thinner." It is a type of heparin. Conditions which increase your risk of developing blood clots include certain types of surgeries (such as knee/hip replacement, abdominal), long periods of being immobile, certain types of heart attack, and a specific type of chest pain called unstable angina. For some medical conditions, enoxaparin may be used in combination with other "blood thinners."

Regulatory & Marketing

Labeler Name
Cardinal Health
FDA Application #
ANDA077857
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-23-2010
End Marketing Date
06-30-2013
Listing Expiration
06-30-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55154-5437-5 identifies a specific commercial package of 5 syringe in 1 bag / 1 ml in 1 syringe of Enoxaparin Sodium, labeled by Cardinal Health. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cardinal Health on July 23, 2010. The current certification is valid through June 30, 2013.

What are the primary indications for this medication?

Enoxaparin is used to prevent and treat harmful blood clots. This helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Enoxaparin is an anticoagulant, also known as a "blood thinner." It is a type of heparin. Conditions which increase your risk of developing blood clots include certain types of surgeries (such as knee/hip replacement, abdominal), long periods of being immobile, certain types of heart attack, and a specific type of chest pain called unstable angina. For some medical conditions, enoxaparin may be used in combination with other "blood thinners."

How is this Cardinal Health product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154543705. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55154-5437-5
11-Digit CMS (5-4-2)
55154-5437-05

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.